This new approach, based on natural selection, dramatically improves the reliability of large language models for practical ...

A demo car ad created with Veo 2 from Google DeepMind is so realistic that it's hard to spot the amazing locations, ...

Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the ...

Hedge fund billionaire Liang Wenfeng builds model on tight budget despite US attempt to halt China’s high-tech ambitions ...

With "Mind Evolution" LLMs can use search and genetic algorithms to generate and combine different solutions and find the optimal one.

Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

The announcement confirms one of two rumors that circled the internet this week. The other was about superintelligence.

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

A string of startups are racing to build models that can produce better and better software. They claim it’s the shortest ...

Google challenges OpenAI with free Gemini 2.0 Flash Thinking model, offering million-token processing, native code execution, and breakthrough performance in math and science benchmarks.